1. Home
  2. HRMY vs NWL Comparison

HRMY vs NWL Comparison

Compare HRMY & NWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$29.34

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Newell Brands Inc.

NWL

Newell Brands Inc.

HOLD

Current Price

$4.03

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
NWL
Founded
2017
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Plastic Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
HRMY
NWL
Price
$29.34
$4.03
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$46.70
$5.68
AVG Volume (30 Days)
605.9K
5.2M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
7.25%
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
$14,742,200,000.00
Revenue This Year
$19.75
$1.19
Revenue Next Year
$12.88
$1.59
P/E Ratio
$10.72
N/A
Revenue Growth
21.51
11.14
52 Week Low
$25.52
$3.07
52 Week High
$40.87
$6.64

Technical Indicators

Market Signals
Indicator
HRMY
NWL
Relative Strength Index (RSI) 56.76 56.94
Support Level $25.92 $3.22
Resistance Level $30.96 $4.84
Average True Range (ATR) 0.82 0.16
MACD 0.42 0.09
Stochastic Oscillator 91.72 94.90

Price Performance

Historical Comparison
HRMY
NWL

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NWL Newell Brands Inc.

Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.

Share on Social Networks: